Lobbying client
PILMA
Pharmaceutical industry concerns as related to workers and business
Filings
66
Filed by
1
Reported in-house
—
Reported by firms
$872,500
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2024
Filings
66 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2024
|
THE MATHIS HARPLE GROUP | — reported |
|
1st Quarter - Report 1st Quarter 2024
|
THE MATHIS HARPLE GROUP | — reported |
|
4th Quarter - Report 4th Quarter 2023
|
THE MATHIS HARPLE GROUP | — reported |
|
3rd Quarter - Amendment 3rd Quarter 2023
|
THE MATHIS HARPLE GROUP | — reported |
|
3rd Quarter - Reportreplaced 3rd Quarter 2023
|
THE MATHIS HARPLE GROUP | — reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
THE MATHIS HARPLE GROUP | — reported |
|
1st Quarter - Report 1st Quarter 2023
|
THE MATHIS HARPLE GROUP | — reported |
|
4th Quarter - Report 4th Quarter 2022
|
THE MATHIS HARPLE GROUP | — reported |
|
3rd Quarter - Report 3rd Quarter 2022
|
THE MATHIS HARPLE GROUP | — reported |
|
2nd Quarter - Report 2nd Quarter 2022
|
THE MATHIS HARPLE GROUP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE MATHIS HARPLE GROUP | 62 | $872,500 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 58 |
| Labor Issues/Antitrust/Workplace | LBR | 6 |
| Copyright/Patent/Trademark | CPT | 1 |
| Health Issues | HCR | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.